A new method to deliver hydrogen sulfide for faster wound healing
HEALS™: An Active Hydrogen Sulfide Delivery Technique for Accelerated, Effective Wound Healing
This study is exploring a new way to help heal stubborn foot wounds in people with diabetes by using a special gas that could boost the body's natural healing abilities, making it easier for these wounds to get better and stay healed.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Exhalix, LLC NIH-funded |
| Lab location | 1 site (Albuquerque, UNITED STATES) |
| Project ID | NIH-10911975 on NIH RePORTER |
What this research studies
This research investigates a novel technique for delivering hydrogen sulfide gas to improve the healing of chronic wounds, particularly in patients with diabetic foot ulcers. The approach aims to address the underlying issues that hinder wound healing, such as poor blood circulation and endothelial dysfunction. By enhancing the body's natural healing processes through targeted delivery of hydrogen sulfide, the research seeks to reduce the high recurrence rates of these wounds. Patients may be monitored for improvements in wound healing and overall recovery.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old suffering from chronic wounds, particularly diabetic foot ulcers.
Not a fit: Patients with wounds not related to diabetes or those with other underlying health conditions that complicate healing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the recurrence of chronic wounds and improve healing outcomes for patients with diabetes.
How similar studies have performed: Previous studies have shown promising results with hydrogen sulfide in promoting wound healing, indicating that this approach may be effective.
Where this research is happening
Albuquerque, UNITED STATES
- Exhalix, LLC — Albuquerque, United States (Active)
Researchers
- Principal investigator: Shekarriz, Reza — Exhalix, LLC
- Study coordinator: Shekarriz, Reza
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.